Colgate-Palmolive Company CL has experienced steady growth over the past year, fueled by its strong leadership in the oral care market and science-driven innovations that have bolstered its core and ...

Colgate-Palmolive Company CL is in a good spot, thanks to its robust business strategies. Strong pricing and funding-the-growth and other productivity initiatives have been bolstering the company’s ...

Colgate-Palmolive and Introgen Therapeutics, Austin, Tex, biotechnology company, announce alliance to incorporate gene therapy into mouthwashes, gels and similar products to treat and prevent oral ...

Colgate-Palmolive achieved over $20 billion in revenue in 2024, driven by strong brand identity, operational discipline, and a diversified product portfolio across Oral Care, Personal Care, Home Care, ...

NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE: CL) today announced that its Net Zero emissions reduction targets have been approved by The Science Based Targets initiative (SBTi). No ...

The last three months of Colgate's fiscal 2024 culminated in 4.3% organic sales growth (balanced between a 2.5% increase in volumes and a 1.8% benefit from higher prices) and 70 basis points of ...

Colgate-Palmolive’s (NYSE:CL) Tom’s of Maine toothpaste was cited by the U.S. Food and Drug Administration for violating Current Good Manufacturing Practices by using contaminated water in its ...

Macro and geopolitical turmoil has failed to deter wide-moat Colgate, as evidenced by the whopping 10% organic sales growth posted in its first quarter, which came on top of similar marks a year ago.

CHICAGO (Reuters) - Procter & Gamble Co and smaller rival Colgate-Palmolive Co posted lower quarterly net income, hurt by sluggish sales in developed markets like the United States and Western Europe.